The US market for cardiac assist devices will grow rapidly over the forecast period, fueled by expanding use of cardiac assist devices into an undertreated patient population, particularly in the temporary VAD market. However, the US cardiac assist device market will be impacted to some extent by the COVID-19 pandemic, resulting in some lost procedure volumes in the short term followed by a period of recovery. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for cardiac assist devices in the US across a 10-year period.

The US cardiac assist device market will be affected by the COVID-19 crisis.

How will the COVID-19 pandemic affect the cardiac assist device market? 

Which market segments will be the most impacted in 2020, and why?

How have companies responded to the obstacles presented by the pandemic?

The VAD market will be the strongest driver of growth in the overall cardiac assist device market.

Which type of VAD—durable or temporary—will generate the most revenues throughout the forecast period?

What are the drivers for growth within the VAD market as a whole, and how do these drivers differ based on VAD durability?

What impact will new technologies in the durable VAD market have throughout the forecast period?

What impact will new competitors in the temporary VAD market have throughout the forecast period?

IABPs were widely used in the US in 2019 for the treatment of AHF.

How will the adoption of temporary VADs affect the IABP market throughout the forecast period?

Table of contents

  • Cardiac Assist Devices - Market Insights - United States
    • Abstract
    • Executive Summary
      • COVID-19 Updates
        • Market Highlights
          • Factors Impacting the Cardiac Assist Device Market, by Product Type, US
          • Cardiac Assist Device Market, by Product Type, US (USD), 2019–2029
          • Cardiac Assist Device Market Landscape, US (USD), 2019 and 2029
        • Competitive Highlights
          • Competitive Factors and Strategies, by Product Type, US
          • Cardiac Assist Device Revenue Market Share Rankings, by Product Type, US, 2019
          • Companies Mentioned
        • Market Developments
          • Recent Events in the Cardiac Assist Device Market, US
          • Key Clinical Trials in the Cardiac Assist Market, US
          • Emerging Products for the Cardiac Assist Device Market, US
        • Procedures Covered
          • Cardiac Assist Device Procedures Covered, US
        • Products Covered
          • Cardiac Assist Devices Covered, US
      • Key Report Updates
        • COVID-19 Analysis
          • Market Impact
            • COVID-19 Impact Assessment Summary, Cardiac Assist Device Market, US
          • Guidance and Recommendations
            • Guidance and Recommendations for Cardiac Assist Device Procedures
          • Major Market Forecast Changes and Assumptions
            • Cardiac Assist Device Market, by Product Type, US (USD), 2019–2029 (Excluding COVID-19 Impact)
            • Cardiac Assist Device Market, by Product Type, US (USD), 2019–2029 (Including COVID-19 Impact)
          • Competitive Impact
            • COVID-19 Competitive Factors and Strategies, Cardiac Assist Device Market, US
            • COVID-19 Impact by Competitor, Cardiac Assist Device Market, US
        • Cardiac Assist Device Market
          • Market Highlights
            • Factors Impacting the Cardiac Assist Device Market, by Product Type, US
            • Cardiac Assist Device Market, by Product Type, US (USD), 2019–2029
          • Market Definitions
            • Market Forecast Data
              • Cardiac Assist Device Procedures, by Product Type, US, 2019–2029
              • Cardiac Assist Device Market, by Product Type, US (USD), 2019–2029
            • Competitive Highlights
              • Market Shares
                • Cardiac Assist Device Revenue Market Shares, US, 2019
                • Cardiac Assist Device Revenue Market Shares, by Product Type, US, 2019
              • Competitive Factors and Strategies
                • Competitive Factors and Strategies, by Product Type, US
              • Market Developments
                • Recent Events in the Cardiac Assist Device Market, US
                • Key Clinical Trials in the Cardiac Assist Market, US
                • Emerging Products for the Cardiac Assist Device Market, US
            • Ventricular Assist Device Market
              • Market Highlights
                • VAD Market, by Durability, US (USD), 2019–2029
              • Market Definitions
                • Market Forecast Data
                  • VAD Procedures, by Durability, US, 2019–2029
                  • VAD Market, by Durability, US (USD), 2019–2029
                  • VAD Market Growth, by Durability, US, 2020–2029
                  • Temporary VAD Procedures, by Technique, US, 2019–2029
                  • Temporary VAD Market, by Technique, US (USD), 2019–2029
                  • Temporary VAD Market Growth, by Technique, US, 2020–2029
                • Competitive Highlights
                  • Market Shares
                    • VAD Revenue Market Shares, US, 2019
                    • VAD Revenue Market Shares, by Durability, US, 2019
                  • Competitive Factors and Strategies
                    • Competitive Factors and Strategies, by Product Type, US
                • Intra-Aortic Balloon Pump System Market
                  • Market Highlights
                    • IABP System Market, by Component, US (USD), 2019–2029
                  • Market Definitions
                    • Market Forecast Data
                      • IABP Procedures, US, 2019–2029
                      • IABP System Capital Equipment Installed Base, US, 2019–2029
                      • IABP System Market, by Component, US (USD), 2019–2029
                      • IABP System Market Growth, by Component, US, 2020–2029
                    • Competitive Highlights
                      • Market Shares
                        • IABP System Revenue Market Shares, US, 2019
                        • IABP System Revenue Market Shares, US, 2019 (1)
                      • Competitive Factors and Strategies
                        • Competitive Factors and Strategies, by Product Type, US
                    • Total Artificial Heart Market
                      • Market Highlights
                        • TAH Market, US (USD), 2019–2029
                      • Market Definitions
                        • Market Forecast Data
                          • TAH Market, US (USD), 2019–2029
                        • Competitive Highlights
                          • Market Shares
                            • TAH Revenue Market Shares, US, 2019
                          • Competitive Factors and Strategies
                            • Competitive Factors and Strategies, US
                        • Remote Hemodynamic Monitoring System Market
                          • Market Highlights
                            • Remote Hemodynamic Monitoring Market, US (USD), 2019–2029
                          • Market Definitions
                            • Market Forecast Data
                              • Remote Hemodynamic Monitoring System Market, US (USD), 2019–2029
                            • Competitive Highlights
                              • Market Shares
                                • Remote Hemodynamic Monitoring System Market Shares, US, 2019
                              • Competitive Factors and Strategies
                                • Competitive Factors and Strategies, US
                            • Appendix
                              • Abbreviations
                                • Bibliography

                              Author(s): Drew Wallace

                              Drew C. Wallace is an analyst on the Cardiovascular Medtech Insights team, specializing in heart valve and cardiac rhythm management device markets. Drew holds a Master's degree in Developmental Biology from the University of Western Ontario. Prior to his current position, Drew worked at the Princess Margaret Cancer Centre on the immunotherapy clinical trial program.